Clinical Features and Long-term Outcomes of Infant Leukemias: A Review of Ten-Years' Experiences.
- Author:
Jee Hyun JEON
1
;
Ye Na CHOI
;
Mi Na KI
;
Seung Hwan OH
;
Churl Joo LYU
;
Chang Hyun YANG
;
Kir Young KIM
Author Information
1. Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea. yangch22@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Infant leukemia;
Clinical feature;
Prognostic factor
- MeSH:
Anemia;
Child;
Diagnosis;
Female;
Fever;
Hepatomegaly;
Humans;
Infant*;
Leukemia*;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
Leukemia, Myeloid, Acute;
Leukocyte Count;
Male;
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;
Precursor Cell Lymphoblastic Leukemia-Lymphoma;
Prognosis;
Remission Induction;
Survival Rate;
Thrombocytopenia;
Treatment Outcome
- From:Korean Journal of Pediatric Hematology-Oncology
2002;9(1):46-53
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Infant leukemia is rare and accounts for 5% of leukemia in children. It differs from childhood leukemia in biologic and clinical features and has a poor prognosis. Research on infant leukemia is difficult due to the scarcity of cases. We studied the clinical progress and prognosis of infant leukemia diagnosed in our hospital, in order to contribute to the treatment and prognosis of infant leukemia. METHODS: The patients who were diagnosed with leukemia in the first 12 months of life were analysed between January 1991 and December 2000 in Yonsei Medical Center. We analysed the sex, age, clinical features, treatment outcome, prognostic factor, and survival rate. RESULTS: Among a total of 41 cases, 19 cases were diagnosed with acute lymphoblastic leukemia (ALL), 15 cases with acute myelogenous leukemia (AML), 2 cases with chronic myelogenous leukemia (CML), and 5 cases were unclassifed. Twenty-two were males and 19 females; age at diagnosis was 4 months in ALL, 8 months in AML, and 4 months in CML. Common clinical features at diagnosis were pale appearance and fever, others were poor oral intake, abdominal distension, and irritability. Hyperleukocytosis with average over 20,000/mm3, anemia, and thrombocytopenia were seen. By immunologic surface marker analysis, 8 of 15 B-lineage ALL were CALLA negative, early pre-B ALL. The remission induction rate was 79% in ALL and 60% in AML. The 5 year-survival rate of 41 patients was 29.2%. Sex, age at diagnosis, white blood cell count > 50 109/L, hepatomegaly, and CNS involvement were not prognostic factors. CONCLUSION: Infant leukemia differs from childhood leukemia in biological and clinical features and has a poor prognosis. Therefore, further clinical research is needed to improve the outcome of infant leukemia.
